| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |